Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Mauro Gacci,Karl‐Erik Andersson,Christopher R. Chapple,Mario Maggi,Vincenzo Mirone,Matthias Oelke,Hartmut Porst,Claus G. Roehrborn,Christian G. Stief,François Giuliano